Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions.
Di Stefano AL, Picca A, Saragoussi E, Bielle F, Ducray F, Villa C, Eoli M, Paterra R, Bellu L, Mathon B, Capelle L, Bourg V, Gloaguen A, Philippe C, Frouin V, Schmitt Y, Lerond J, Leclerc J, Lasorella A, Iavarone A, Mokhtari K, Savatovsky J, Alentorn A, Sanson M; TARGET study group. Di Stefano AL, et al. Among authors: bourg v. Neuro Oncol. 2020 Nov 26;22(11):1614-1624. doi: 10.1093/neuonc/noaa121. Neuro Oncol. 2020. PMID: 32413119 Free PMC article.
Peri-ictal pseudoprogression in patients with brain tumor.
Rheims S, Ricard D, van den Bent M, Taillandier L, Bourg V, Désestret V, Cartalat-Carel S, Hermier M, Monjour A, Delattre JY, Sanson M, Honnorat J, Ducray F. Rheims S, et al. Among authors: bourg v. Neuro Oncol. 2011 Jul;13(7):775-82. doi: 10.1093/neuonc/nor082. Neuro Oncol. 2011. PMID: 21727213 Free PMC article.
Characteristics of H3 K27M-mutant gliomas in adults.
Meyronet D, Esteban-Mader M, Bonnet C, Joly MO, Uro-Coste E, Amiel-Benouaich A, Forest F, Rousselot-Denis C, Burel-Vandenbos F, Bourg V, Guyotat J, Fenouil T, Jouvet A, Honnorat J, Ducray F. Meyronet D, et al. Among authors: bourg v. Neuro Oncol. 2017 Aug 1;19(8):1127-1134. doi: 10.1093/neuonc/now274. Neuro Oncol. 2017. PMID: 28201752 Free PMC article.
Complementary and alternative medicine use in glioma patients in France.
Le Rhun E, Devos P, Bourg V, Darlix A, Lorgis V, Ahle G, Boone M, Taillandier L, Curtit E, Gras L, Lebrun Frenay C, Gramatzki D, Ramirez C, Simon N, Weller M. Le Rhun E, et al. Among authors: bourg v. J Neurooncol. 2019 Dec;145(3):487-499. doi: 10.1007/s11060-019-03315-8. Epub 2019 Oct 21. J Neurooncol. 2019. PMID: 31637628 Free article.
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults.
Picart T, Barritault M, Poncet D, Berner LP, Izquierdo C, Tabouret E, Figarella-Branger D, Idbaïh A, Bielle F, Bourg V, Vandenbos FB, Moyal EC, Uro-Coste E, Guyotat J, Honnorat J, Gabut M, Meyronet D, Ducray F. Picart T, et al. Among authors: bourg v. Neurooncol Adv. 2021 Apr 19;3(1):vdab061. doi: 10.1093/noajnl/vdab061. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34056608 Free PMC article.
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, Ansell PJ, Samanta S, Kundu MG, Armstrong TS, Wefel JS, Seidel C, de Vos FY, Hsu S, Cardona AF, Lombardi G, Bentsion D, Peterson RA, Gedye C, Bourg V, Wick A, Curran WJ, Mehta MP. Lassman AB, et al. Among authors: bourg v. Neuro Oncol. 2023 Feb 14;25(2):339-350. doi: 10.1093/neuonc/noac173. Neuro Oncol. 2023. PMID: 35849035 Free PMC article. Clinical Trial.
Long-term outcome of oligodendrogliomas.
Lebrun C, Fontaine D, Ramaioli A, Vandenbos F, Chanalet S, Lonjon M, Michiels JF, Bourg V, Paquis P, Chatel M, Frenay M; Nice Brain Tumor Study Group. Lebrun C, et al. Among authors: bourg v. Neurology. 2004 May 25;62(10):1783-7. doi: 10.1212/01.wnl.0000125196.88449.89. Neurology. 2004. PMID: 15159478
68 results